4//SEC Filing
Hicks Derek 4
Accession 0000950170-24-025903
CIK 0001652130other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:10 PM ET
Size
7.0 KB
Accession
0000950170-24-025903
Insider Transaction Report
Form 4
Hicks Derek
EVP, Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2024-03-01+42,421→ 42,421 totalExercise: $32.66Exp: 2034-02-28→ Common Stock (42,421 underlying) - Award
Common Stock
2024-03-01+29,393→ 66,380 total
Footnotes (2)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001901282
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:10 PM ET
- Size
- 7.0 KB